DODC

DODC

DODC

Chemical compound

For the fictional organization, see United States Department of Damage Control.

DODC is a psychedelic drug from the substituted amphetamine family which acts as an agonist of the 5-HT2A receptor. It is the 3,4-dichloro derivative of the well known psychedelic drug 2,5-Dimethoxy-4-chloroamphetamine (DOC). DODC was first officially published in a patent filed by Gilgamesh Pharmaceuticals in 2020,[1] though anecdotal reports suggest it had been synthesised by clandestine chemists and its activity established several years prior to this.

Quick Facts Identifiers, CAS Number ...

See also

References

  1. [1]
    WO 2022/006186, Kruegel AC, "Phenalkylamines and Methods of Treating Mood Disorders.", published January 2022, assigned to Gilgamesh Pharmaceuticals.



Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article DODC, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.